Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00418574
What this trial is testing

Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Menarini Group 888
Large-scale testing (Phase 3)Ended earlyNCT01849874
What this trial is testing

MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Low-grade Serous Ovarian CancerLow-grade Serous Fallopian Tube CancerLow-grade Serous Peritoneal Cancer
Pfizer 341
Testing effectiveness (Phase 2)Looking for participantsNCT05797168
What this trial is testing

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Who this might be right for
Ovarian CancerLung AdenocarcinomaEndometrial Cancer+1 more
AstraZeneca 602
Testing effectiveness (Phase 2)Study completedNCT00032162
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+2 more
AGO Study Group 63
Early research (Phase 1)Study completedNCT01459380
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Ovarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)UnknownNCT04566952
What this trial is testing

Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian and Fallopian Tube Cysts and NeoplasmsNeoplasms by Site+16 more
Xiaoxiang Chen 68
Early research (Phase 1)Study completedNCT03719326
What this trial is testing

Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies

Who this might be right for
TNBC - Triple-Negative Breast CancerOvarian Cancer
Arcus Biosciences, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT02725489
What this trial is testing

Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Who this might be right for
Breast CancerOvarian CancerFallopian Tube Cancer+4 more
Mary Crowley Medical Research Center 13
Testing effectiveness (Phase 2)Ended earlyNCT03300843
What this trial is testing

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaGastrointestinal CancerBreast Cancer+2 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT02179515
What this trial is testing

Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)

Who this might be right for
Lung CancerBreast CancerProstate Cancer+2 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Early research (Phase 1)Ended earlyNCT03691376
What this trial is testing

Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+9 more
Roswell Park Cancer Institute 4
Not applicableUnknownNCT00595348
What this trial is testing

Korean Hereditary Breast Cancer Study

Who this might be right for
Breast CancerOvarian Cancer
Korean Breast Cancer Study Group 2,250
Testing effectiveness (Phase 2)Study completedNCT02440425
What this trial is testing

Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Not applicableStudy completedNCT01262040
What this trial is testing

Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+5 more
Memorial Sloan Kettering Cancer Center 154
Testing effectiveness (Phase 2)UnknownNCT05479487
What this trial is testing

Fluzoparib and Apatinib Versus Fluzoparib in Relapsed Ovarian Carcinoma Maintenance Treatment

Who this might be right for
Relapsed Ovarian Cancer
Xiaohua Wu MD 132
Not applicableStudy completedNCT04785716
What this trial is testing

Real-life Use of Niraparib in a Patient Access Program in Norway

Who this might be right for
Ovarian CancerPeritoneal Cancer
Kristina Lindemann 106
Not applicableStudy completedNCT01544049
What this trial is testing

Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

Who this might be right for
Ovarian Cancer
University of Washington 24
Next Page